An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors

Clinical trial NCT05481502 · RECRUITING

Trial details

NCT number: NCT05481502
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Solid Tumor, Adult Solid Tumor, Childhood Hematologic Cancer

Start date: 2022-06-08
Primary completion: 2027-07-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.